Liposome mediated drug delivery for leukocyte adhesion deficieny I (LAD I): Targeting the mutated gene ITGB2 and expression of CD18 protein

C. Subathra DEVI, Kritika KEDARINATH, Payal CHOUDHARY, Vishakha TYAGI, Mohanasrinivasan. V

PDF(104 KB)
PDF(104 KB)
Front. Biol. ›› 2014, Vol. 9 ›› Issue (1) : 1-4. DOI: 10.1007/s11515-013-1287-6
MINI-REVIEW
MINI-REVIEW

Liposome mediated drug delivery for leukocyte adhesion deficieny I (LAD I): Targeting the mutated gene ITGB2 and expression of CD18 protein

Author information +
History +

Abstract

Leukocyte adhesion deficiency (LAD) I is a disorder caused due to mutations in a gene (ITGB2) located on chromosome 21 and encodes the β2 subunit of the leukocyte integrin molecules. This leads to defects in the adhesion of leukocytes on endothelial cells which further leads to recurrent microbial infections due to a decrease in the immune response. Base Excision Repair Mechanism (BER) is instrumental in repairing damaged DNA by removing mutated/damaged bases. We have proposed a hypothesis for the treatment of LAD I by making use of the proteins/enzyme complexes responsible for base excision repair mechanism be introduced into the leukocytes via liposomes. This will target the mutated gene in the leukocytes (mostly neutrophils) and DNA repair will occur. The liposomes can be introduced into the patients via intravenous methods.

Graphical abstract

Keywords

CD18 / β-integrin / LAD I / liposome / BER / ITGB2

Cite this article

Download citation ▾
C. Subathra DEVI, Kritika KEDARINATH, Payal CHOUDHARY, Vishakha TYAGI, Mohanasrinivasan. V. Liposome mediated drug delivery for leukocyte adhesion deficieny I (LAD I): Targeting the mutated gene ITGB2 and expression of CD18 protein. Front. Biol., 2014, 9(1): 1‒4 https://doi.org/10.1007/s11515-013-1287-6

References

[1]
Akbari M, Otterlei M, Peña-Diaz J, Aas P A, Kavli B, Liabakk N B, Hagen L, Imai K, Durandy A, Slupphaug G, Krokan H E (2004). Repair of U/G and U/A in DNA by UNG2-associated repair complexes takes place predominantly by short-patch repair both in proliferating and growth-arrested cells. Nucleic Acids Res, 32(18): 5486−5498
CrossRef Pubmed Google scholar
[2]
Allen T M, Hansen C B, Guo L S (1993). Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim Biophys Acta, 1150(1): 9−16
CrossRef Pubmed Google scholar
[3]
Amin A M, Dana N, Gupta S K, Tenen D G, Fathallah D M (1990). Point Mutations Impairing Cell Surface Expression of the Common β Subunit (CD18) in a Patient with Leukocyte Adhesion Molecule (Leu-CAM) Deficiency. American Soc Clin Invest. Inc., 85: 977−981
[4]
Anderson D C, Springer T A (1987). Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med, 38(1): 175−194
CrossRef Pubmed Google scholar
[5]
Chaudhuri J, Alt F W (2004). Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol, 4(7): 541−552
CrossRef Pubmed Google scholar
[6]
Finkelstein M, Weissmann G (1978). The introduction of enzymes into cells by means of liposomes. J Lipid Res, 19(3): 289−303
Pubmed
[7]
Fortini P, Dogliotti E (2007). Base damage and single-strand break repair: mechanisms and functional significance of short- and long-patch repair subpathways. DNA Repair (Amst), 6(4): 398−409
CrossRef Pubmed Google scholar
[8]
Fromme J C, Banerjee A, Verdine G L (2004). DNA glycosylase recognition and catalysis. Curr Opin Struct Biol, 14(1): 43−49
CrossRef Pubmed Google scholar
[9]
Kishimoto T K, O’Conner K, Springer T A (1989). Leukocyte adhesion deficiency. Aberrant splicing of a conserved integrin sequence causes a moderate deficiency phenotype. J Biol Chem, 264(6): 3588−3595
Pubmed
[10]
Kuhn S H, Gemperli B, Shephard E G, Joubert J R, Weidemann P A, Weissmann G, Finkelstein M C (1983). Interaction of liposomes with human leukocytes in whole blood. Biochim Biophys Acta, 762(1): 119−127
CrossRef Pubmed Google scholar
[11]
Lehman I R (1974). DNA ligase: structure, mechanism, and function. Science, 186(4166): 790−797
CrossRef Pubmed Google scholar
[12]
Liu Y, Prasad R, Beard W A, Kedar P S, Hou E W, Shock D D, Wilson S H (2007). Coordination of steps in single-nucleotide base excision repair mediated by apurinic/apyrimidinic endonuclease 1 and DNA polymerase β. J Biol Chem, 282(18): 13532−13541
CrossRef Pubmed Google scholar
[13]
Marenstein D R, Wilson D M 3rd, Teebor G W (2004). Human AP endonuclease (APE1) demonstrates endonucleolytic activity against AP sites in single-stranded DNA. DNA Repair (Amst), 3(5): 527−533
CrossRef Pubmed Google scholar
[14]
Mayer L D, Tai L C, Ko D S, Masin D, Ginsberg R S, Cullis P R, Bally M B (1989). Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res, 49(21): 5922−5930
Pubmed
[15]
Ristori S, Oberdisse J, Grillo I, Donati A, Spalla O (2005). Structural characterization of cationic liposomes loaded with sugar-based carboranes. Biophys J, 88(1): 535−547
CrossRef Pubmed Google scholar
[16]
Schreiber V, Amé J C, Dollé P, Schultz I, Rinaldi B, Fraulob V, Ménissier-de Murcia J, de Murcia G (2002). Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem, 277(25): 23028−23036
CrossRef Pubmed Google scholar
[17]
Sidorenko V S, Zharkov D O (2008). Role of base excision repair DNA glycosylases in hereditary and infectious human diseases. Молекул биол, 42(5): 891−903
Pubmed
[18]
Steitz T A (1999). DNA polymerases: structural diversity and common mechanisms. J Biol Chem, 274(25): 17395−17398
CrossRef Pubmed Google scholar
[19]
Stephen J N, Robert A S, Monika I S (2012).
[20]
Szebeni J (1998). The Interaction of Liposomes with the Complement. Crit Rev Ther Drug, 15(1): 32
CrossRef Google scholar
[21]
Wagner A,Vorauer-Uhl K (2011). Liposome technology for industrial purposes. J Drug Delivery, Article ID 591325
[22]
Working P K, Newman M S, Huang S K, Mayhew E, Vaage J, Lasic D D (1994). Pharmacokinetics, biodistribution, and therapeutic efficacy of doxorubicin encapsulated in Stealth® liposomes (Doxil®). J Liposome Res, 4(1): 667−687
CrossRef Google scholar
[23]
Zhang X W, Schramm R, Liu Q, Ekberg H, Jeppsson B, Thorlacius H (2000). Important role of CD18 in TNF-alpha-induced leukocyte adhesion in muscle and skin venules in vivo. Inflamm Res, 49(10): 529−534
CrossRef Pubmed Google scholar
[24]
Zharkov D O (2007). Structure and conformational dynamics of base excision repair DNA glycosylases. Mol Biol, 41(5): 702−716
CrossRef Google scholar

Acknowledgements

The authors thank the management of the VIT University for providing the facilities to carry out this study.
Conflict of interest
Subathra, Kritika, Payal, Tyagi and Mohanasrinivasan declare that they have no conflict of interest.

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg
PDF(104 KB)

Accesses

Citations

Detail

Sections
Recommended

/